Your browser doesn't support javascript.
loading
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Kawai, Hironari; Osawa, Yosuke; Matsuda, Michitaka; Tsunoda, Tomoyuki; Yanagida, Keisuke; Hishikawa, Daisuke; Okawara, Miku; Sakamoto, Yuzuru; Shimagaki, Tomonari; Tsutsui, Yuriko; Yoshida, Yuichi; Yoshikawa, Shiori; Hashi, Kana; Doi, Hiroyoshi; Mori, Taizo; Yamazoe, Taiji; Yoshio, Sachiyo; Sugiyama, Masaya; Okuzaki, Daisuke; Komatsu, Haruki; Inui, Ayano; Tamura-Nakano, Miwa; Oyama, Chinatsu; Shindou, Hideo; Kusano, Hironori; Kage, Masayoshi; Ikegami, Toru; Yanaga, Katsuhiko; Kanto, Tatsuya.
Affiliation
  • Kawai H; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Osawa Y; Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Matsuda M; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Tsunoda T; Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Tochigi, Japan.
  • Yanagida K; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Hishikawa D; Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama-shi Tobu Hospital, Kanagawa, Japan.
  • Okawara M; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sakamoto Y; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan.
  • Shimagaki T; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Tsutsui Y; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Yoshida Y; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Yoshikawa S; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Hashi K; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Doi H; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Mori T; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Yamazoe T; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Yoshio S; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Sugiyama M; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Okuzaki D; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Komatsu H; Genome Medical Sciences Project, National Center for Global Health and Medicine, Chiba, Japan.
  • Inui A; Genome information Research Center, Research Institute for Microbial Disease, Osaka University, Suita, Osaka, Japan.
  • Tamura-Nakano M; Department of Pediatrics, Toho University Medical Center, Sakura hospital, Chiba, Japan.
  • Oyama C; Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama-shi Tobu Hospital, Kanagawa, Japan.
  • Shindou H; Communal Laboratory, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kusano H; Communal Laboratory, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kage M; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ikegami T; Department of Lipid Science, The University of Tokyo, Tokyo, Japan.
  • Yanaga K; Department of Pathology, Kurume University School of Medicine, Fukuoka, Japan.
  • Kanto T; Kurume University Research Center for Innovative Cancer Therapy, Fukuoka, Japan.
Hepatology ; 76(1): 112-125, 2022 07.
Article de En | MEDLINE | ID: mdl-34855990

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies vasculaires / Carcinome hépatocellulaire / Défaillance cardiaque / Tumeurs du foie Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Hepatology Année: 2022 Type de document: Article Pays d'affiliation: Japon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies vasculaires / Carcinome hépatocellulaire / Défaillance cardiaque / Tumeurs du foie Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Hepatology Année: 2022 Type de document: Article Pays d'affiliation: Japon